BRCA mutation variants in ovarian cancer patients: Does the mutation class matter? von Grzankowski, K.S, Brightwell, R, Hutton, M, Akers, S.N

Volltext

Evaluation of the impact of chronic steroid use on outcomes in gynecologic cancer patients: A NSQIP database analysis von Szender, J.B, Grzankowski, K.S, Akers, S.N, Zsiros, E, Odunsi, K.O, Lele, S.B

Volltext

Investigating the impact of asymptomatic leukocytosis on postoperative outcomes in ovarian cancer von Szender, J.B, Grzankowski, K.S, Akers, S.N, Frederick, P.J, Lele, S.B, Odunsi, K.O

Volltext

Evaluation of a universal surgical risk calculator for quality improvement on a gynecologic oncology service von Frederick, P.J, Akers, S.N, Lele, S.B, Odunsi, K.O

Volltext

Oxaliplatin is a safe alternative therapeutic option for patients with recurrent gynecologic cancers following hypersensitivity reaction to carboplatin von Miller, A, Riebandt, G, Blum, B, Hacker, K, Akers, S.N, Odunsi, K.O, Lele, S.B, Frederick, P.J

Volltext

Gamma synuclein expression in ovarian cancer von Akers, S.N, Bshara, W, Buttin, B, Frederick, P, Helenowski, I, Morrison, C.D, Odunsi, K, Schink, J, Scholtens, D, Wei, J.J, Kim, J.J

Volltext

Utilization and prognostic impact of somatic tumor testing in ovarian cancer: A single-institution experience von Lynam, S., Recio, F.O., Roy, M., Belliotti, S., Akers, S.N., Frederick, P.J., Lele, S.B., Zsiros, E., Eng, K.H., Odunsi, K.

Volltext

Video-based counseling and point-of-contact testing improves genetic screening completion in an ovarian cancer patient population von Lynam, S., Dowling, J., Hutton, M., Wypij, H., Odunsi, K., Lele, S.B., Zsiros, E., Akers, S.N., Frederick, P.J.

Volltext

A phase II trial of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer von Zsiros, E., Frederick, P.J., Akers, S.N., Attwood, K., Wang, K., Lele, S.B., Odunsi, K.

Volltext

TIGIT ligands CD155, CD112, and galectin-9 are associated with immune infiltration and increased overall survival in ovarian cancer von Starbuck, K., Morrell, K., Odunsi, K., Zsiros, E., Szender, J.B., Frederick, P.J., Lele, S.B., Akers, S.N., Eng, K.H.

Volltext

Performing combined breast and gynecologic surgery does not increase the rate of postoperative morbidity von Mayor, P.C., Fan, K., Etter, J.L., Morrell, K., Eng, K.H., Szender, J.B., Akers, S.N., Frederick, P.J., Lele, S.B., Odunsi, K., Zsiros, E.

Volltext

Tackling the opioid crisis: Implementation of an ultra-restrictive opioid prescription protocol in patients undergoing major gynecologic surgery radically decreased dispensed opioi... von Mark, J.E., Phoenix, D., Gutierrez, C.A., Morrell, K., Eng, K.H., Mayor, P.C., Akers, S.N., Lele, S.B., Odunsi, K., DeLeon, O., Frederick, P.J., Zsiros, E.

Volltext

Prognostic impact of adjuvant chemotherapy treatment delays for ovarian cancer: A cohort study von Starbuck, K., Eng, K.H., Morrell, K., Duncan, W., Etter, J.L., Moysich, K.B., Odunsi, K., Zsiros, E., Frederick, P.J., Akers, S.N., Lele, S.B., Szender, J.B.

Volltext

Proton pump inhibitor use during chemotherapy for platinum-resistant or platinum-refractory ovarian cancer improves overall survival von Starbuck, K., Belliotti, S., Morrell, K., Etter, J.L., Kolesnikova, K., Zsiros, E., Odunsi, K., Lele, S.B., Frederick, P.J., Akers, S.N., Eng, K.H.

Volltext

A comprehensive genomic analysis of neuroendocrine carcinoma of gynecologic and breast tumors von Mayor, P.C., Gay, L., Fan, K., Frederick, P.J., Eskander, R.N., Sun, J., Ross, J.S., Kurzrock, R., Akers, S.N., Lele, S.B., Odunsi, K., Zsiros, E., Elvin, J.A.

Volltext

Operative time is a major modifiable risk factor impacting surgical outcomes in patients undergoing pelvic exenteration for gynecologic malignancy von Mayor, P.C., Fan, K., Etter, J.L., Szender, J.B., Morrell, K., Eng, K.H., Akers, S.N., Frederick, P.J., Odunsi, K., Lele, S.B., Zsiros, E.

Volltext

Surgery induces broad changes in clinically relevant genes regulating immune and metabolic responses in murine epithelial ovarian cancer von Mayor, P.C., Akers, S.N., Frederick, P.J., Lele, S.B., Gomez, E. Cortes, Wang, J., Lynam, S., Mark, J.E., Starbuck, K., Zsiros, E., Singel, K.L., Odunsi, K., Ohm, J., Segal, B.H.

Volltext

Variability in body mass index (BMI) during adjuvant chemotherapy is associated with clinical outcomes among invasive ovarian cancer patients von Starbuck, K., Cannioto, R.A., Etter, J.L., Moysich, K.B., Duncan, W., Morrell, K., Almohanna, H., Joseph, J.M., Szender, J.B., Zsiros, E., Odunsi, K., Frederick, P.J., Lele, S.B., Akers, S.N., Eng, K.H.

Volltext

Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study von Akers, S N, Riebandt, G, Miller, A, Groman, A, Odunsi, K, Lele, S

Volltext

Effects of intramammary infection and parenchymal region on collagen abundance in nonlactating bovine mammary glands von Enger, B.D., Lehner, S.N., Parsons, C.L.M., Akers, R.M., Hardy, N.R.

Volltext